BNET Industries

Pfizer Inc.

(PFE) is in the Pharma Industry

Market Cap:$147.8B

Last Fiscal Year Sales:$48.4B

Public
US

Dow Jones Description

Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.

Number of Employees 81,800

Contact Information

235 E 42nd St

New York, New York 10017-5755

www.pfizer.com

(212) 573-2323

Peer Companies

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Company News

Recent Events

Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research

12/11/09 - Joint Venture / Alliance - View Story
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...

12/08/09 - Joint Venture / Alliance - View Story
Science and Technology: Pfizer to buy Croatian drug patent

12/07/09 - Joint Venture / Alliance - View Story
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update

12/04/09 - Joint Venture / Alliance - View Story
'IT boosts efficiency & innovation'

12/04/09 - Merger / Acquisition - View Story
Inspector General Saved Billions in Healthcare This Year

12/04/09 - Legal Settlement - View Story
Pfizer and B.C. launch $9M collaboration to tackle cancer

12/03/09 - Joint Venture / Alliance - View Story
Reportlinker Adds Growth Factors Blood And Tissue - A World Report

12/02/09 - Joint Venture / Alliance - View Story
Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease

12/10/09 - Joint Venture / Alliance - View Story
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M

12/02/09 - Joint Venture / Alliance - View Story
Conservationists salute two corporations

12/06/09 - Merger / Acquisition - View Story
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV

11/24/09 - Joint Venture / Alliance - View Story
2009: The Year That Was For Pfizer

12/08/09 - Financial Announcement - View Story
A 2nd Loss for Pfizer in Drug Suits

11/23/09 - Legal Settlement - View Story
Pfizer acquires stem cell therapies assets of Axordia

11/23/09 - Merger / Acquisition - View Story
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24

11/23/09 - Bond / Stock Rating - View Story
ImmunoVaccine signs exclusive licence deal with Pfizer

11/23/09 - Joint Venture / Alliance - View Story
Pfizer Animal Health selects Bader Rutter as agency of record

11/17/09 - Licensing / Contract - View Story

News & Analysis

Filter by

Sort Type

hartford courant and merger and pfizer inc. - All News and Analysis

Pfizer Merger May Crimp Innovation.

- 2003-05-02

By Dan Haar, The Hartford Courant, Conn. Knight Ridder/Tribune Business News By Dan Haar, The Hartford Courant, Conn. Knight Ridder/Tribune Business News

Tags: Hartford Courant, merger, Pfizer Inc.
Economists Say Connecticut Could Feel Later Effects of Pfizer Merger.

- 2003-05-01

By Stacy Wong, The Hartford Courant, Conn. Knight Ridder/Tribune Business News By Stacy Wong, The Hartford Courant, Conn. Knight Ridder/Tribune Business News

Tags: Hartford Courant, merger, Pfizer Inc.
Southeastern Connecticut Pfizer Research Facilities Escape Merger-Related Cuts.

- 2003-04-01

By John M. Moran, The Hartford Courant, Conn. Knight Ridder/Tribune Business News By John M. Moran, The Hartford Courant, Conn. Knight Ridder/Tribune Business News

Tags: Hartford Courant, merger, Pfizer Inc.